Page 26 - scheppingen
P. 26

 one
24
74. Lee DY. Roles of mTOR Signaling in Brain Development. Exp Neurobiol. 2015 Sep;24(3):177-85.
75. Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014 Oct 22;84(2):275-91.
76. Crino PB. mTOR signaling in epilepsy: insights from malformations of cortical development. Cold
Spring Harb Perspect Med. 2015 Apr;5(4).
77. Crino PB. The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev
Neurol. 2016 Jul;12(7):379-92.
78. Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017 Mar
09;168(6):960-76.
79. Tee AR, Sampson JR, Pal DK, Bateman JM. The role of mTOR signalling in neurogenesis, insights
from tuberous sclerosis complex. Semin Cell Dev Biol. 2016 Apr;52:12-20.
80. Crino PB. Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy. Annals of
neurology. 2008 Apr;63(4):415-7.
81. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclero-
sis complex. Lancet Neurol. 2015 Jul;14(7):733-45.
82. Harvey AS, Cross JH, Shinnar S, Mathern GW, Taskforce IPESS. Defining the spectrum of interna-
tional practice in pediatric epilepsy surgery patients. Epilepsia. 2008 Jan;49(1):146-55.
83. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods
Commission. Epilepsia. 2011 Jan;52(1):158-74.
84. Crino PB. Focal brain malformations: a spectrum of disorders along the mTOR cascade. Novartis
Found Symp. 2007;288:260-72; discussion 72-81.
85. Crino PB. Focal brain malformations: seizures, signaling, sequencing. Epilepsia. 2009 Oct;50 Suppl
9:3-8.
86. Wong M. Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent prog-
ress toward clinical applications. Epilepsia. 2009 Oct;50 Suppl 9:34-44.
87. Aronica E, Becker AJ, Spreafico R. Malformations of cortical development. Brain pathology. 2012
May;22(3):380-401.
88. Barkovich AJ, Dobyns WB, Guerrini R. Malformations of cortical development and epilepsy. Cold
Spring Harb Perspect Med. 2015 May 01;5(5):a022392.
89. Desikan RS, Barkovich AJ. Malformations of cortical development. Annals of neurology. 2016
Dec;80(6):797-810.
90. Crino PB. The enlarging spectrum of focal cortical dysplasias. Brain. 2015 Jun;138(Pt 6):1446-8.
91. Lim JS, Gopalappa R, Kim SH, et al. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical
Dysplasia. American journal of human genetics. 2017 Mar 2;100(3):454-72.
92. D’Gama AM, Woodworth MB, Hossain AA, et al. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias. Cell reports. 2017
Dec 26;21(13):3754-66.
93. Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handbook of clinical neurology.
2012;107:163-75.
94. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nature reviews
Neurology. 2011 Jan;7(1):31-40.
95. van Vliet EA, Aronica E, Vezzani A, Ravizza T. Review: Neuroinflammatory pathways as treatment
targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical
studies. Neuropathology and applied neurobiology. 2018 Feb;44(1):91-111.
96. Vezzani A, Lang B, Aronica E. Immunity and Inflammation in Epilepsy. Cold Spring Harb Perspect
Med. 2016 Feb;6(2):a022699.
97. Aronica E, Bauer S, Bozzi Y, et al. Neuroinflammatory targets and treatments for epilepsy validated
in experimental models. Epilepsia. 2017 Jul;58:27-38.
98. Dube CM, Brewster AL, Richichi C, Zha Q, Baram TZ. Fever, febrile seizures and epilepsy. Trends in
neurosciences. 2007 Oct;30(10):490-6.
99. Aronica E, Crino PB. Inflammation in epilepsy: clinical observations. Epilepsia. 2011 May;52 Suppl
3:26-32.
100. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol. 2013
Jun;244:11-21.
101. NguyenMD,JulienJP,RivestS.Innateimmunity:themissinglinkinneuroprotectionandneurode-












































   24   25   26   27   28